Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00919100 · ClinicalTrials.gov registry record · NA
Buzzy Versus Vapocoolant Spray: Pediatric Needle Pain Relief
A NA study of Pain, sponsored by Georgia State University.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
- 1
- Study location
NCT00919100: Completed NA study of Pain, sponsored by Georgia State University.
NCT00919100 is a NA study of Pain that has completed, run by Georgia State University. The registered enrollment target is 81 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00919100, a NA study of Pain, has completed, sponsored by Georgia State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
- 1
- Study location
Study Summary
A vibrating cold pack placed proximal to the site of venipuncture will decrease the pain of cannulation when compared to vapocoolant spray.
Primary Outcome
Self-report measure of pain via 6 faces ranging from neutral to increasing pain expression. The scoring for the scale ranges from 0-10 with lower scores representing lower pain and higher scores representing higher pain. The FPS-R was conducted several minutes following venipuncture. This time was not tracked, but it was typically between 2-5 minutes following completion of the venipuncture.
Conditions Studied
Interventions
- DEVICE Buzzy
- OTHER vapocoolant
Study Locations (1)
Georgia
- Children's Healthcare of Atlanta, Scottish Rite - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2008-04 |
| Est. Completion | 2008-08 |
| Phase | NA |
What the finished NCT00919100 record still lists
NCT00919100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Buzzy is the first listed.
NCT00919100 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT00919100 about?
NCT00919100 is a clinical study titled "Buzzy Versus Vapocoolant Spray: Pediatric Needle Pain Relief". A vibrating cold pack placed proximal to the site of venipuncture will decrease the pain of cannulation when compared to vapocoolant spray.
What is the current status of trial NCT00919100?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2008-04. Estimated completion is 2008-08.
What conditions does trial NCT00919100 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT00919100?
The interventions under investigation include: Buzzy (DEVICE), vapocoolant (OTHER).
Who is sponsoring clinical trial NCT00919100?
This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00919100 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00919100's enrollment target sits among peer trials
81 192nd of 374 higher than 183 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia